SciSparc Announces 1-for-9 Reverse Share Split - SciSparc (NASDAQ:SPRC)

Tel Aviv, Israel, March 02, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. ("SciSparc" or the "Company") (NASDAQ:SPRC), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today that it intends to effect a one-for-nine (1-for-9) reverse share split (the "Reverse Share Split") of the Company's issued and outstanding ordinary shares, no par value per share (the "Ordinary Shares"), effective at the market open on March 4, 2026. The Ordin ...